Iantrek, Inc, a venture-backed, medical technology company pioneering next-generation bio- and micro-interventional technologies for the treatment of ophthalmic diseases, today announced the first ...

"Beacon secures $170m to advance ophthalmic gene therapies" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been ...

The US Food and Drug Administration (FDA) has approved Zeiss Medical Technology’s MEL 90 excimer laser technology. MEL 90 is ...

Eyenovia said it hired Chardan as its financial adviser as it goes through a business review that includes a potential sale of the company.

Eyenovia, Inc., an ophthalmic technology company, has announced it is consulting with Chardan as its financial advisor to explore various strategic alternatives, including potential business ...

11 analysts have expressed a variety of opinions on Glaukos GKOS over the past quarter, offering a diverse set of opinions ...

Advancements in Laser Technology for Ophthalmic Surgery Advancements in laser technology for ophthalmic surgery are revolutionizing eye care, offering new opportunities for the global ophthalmic ...

Norlase, a leading global ophthalmic laser manufacturer developing next-generation laser solutions, today announced it has ...

Utilizing advanced technology for rapidly screening peptides ... the treatment accessibility of AMD and other related ophthalmic conditions. Dr. Seo stated, “The KIST Natural Product Drug ...

(NASDAQ: EYEN) ("Eyenovia” or the "Company”), an ophthalmic technology company focused on completing development of its proprietary Optejet topical ophthalmic medication dispensing platform, today ...